Remove Bacteria Remove Genome Remove Medicine Remove Reagent
article thumbnail

CRISPR breakthroughs: New solutions for common diseases

Drug Discovery World

Rolf Turk , Senior Manager, Genomics Medicine at Integrated DNA Technologies, examines how CRISPR is being used to enhance cancer therapies. These efforts, along with many others, are opening doors for new possibilities in translational medicine. Herpesviridae, Polyomaviridae, and Papillomaviridae), bacteria (e.g.,

DNA 98
article thumbnail

BioSpace Global Roundup: Ipsen Wins Fast Track Designation for Cancer Drug and More

The Pharma Data

aeruginosa bacteria, instead of killing the bacteria as an antibiotic would aim to do. The license from ERS Genomics now enables Vivlion to offer both R&D reagents and screening services to its customers worldwide. Financial details of the agreement were not disclosed.

Drugs 52
article thumbnail

BioSpace Global Roundup, Oct. 15

The Pharma Data

Prestige BioPharma – Singapore-based Prestige received a positive opinion from the European Medicines Agency Orphan Drug Commission (COMP) for its first-in-class anti-PAUF monoclonal antibody, PBP1510, for the treatment of pancreatic cancer. ERS Genomics – Ireland’s ERS Genomics signed an agreement with FASMAC Co., Ltd of Japan.